|
|
||||||||
Ann Thorac Surg 1998;65:149-154
© 1998 The Society of Thoracic Surgeons
Division of Cardiovascular and Thoracic Surgery, Section of Pediatric Cardiology, and Division of Cardiovascular Diseases, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
Dr Danielson, Section of Cardiovascular Surgery, Mayo Clinic, 200 First St, SW, Rochester, MN 55905.
Presented at the Thirty-third Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, Feb 35, 1997.
| Abstract |
|---|
|
|
|---|
Methods. In an effort to reduce the incidence of atrial tachyarrhythmias after repair of right-sided congenital heart disease, we performed a concomitant right-sided maze procedure.
Results. Eighteen patients with paroxysmal atrial fibrillation or flutter (n = 12) or chronic atrial fibrillation or flutter (n = 6) aged 10.9 to 68.4 years (mean 34.9 years) underwent a right-sided maze in association with repair of Ebsteins anomaly (n = 15), congenital tricuspid insufficiency (n = 2), and isolated atrial septal defect (n = 1). There were no early deaths, reoperations, or complete heart block. Discharge rhythm was sinus (n = 16) or junctional (n = 2). Follow-up was complete in all 18 patients and ranged from 3.1 to 17.2 months (mean 8.1 months); all are in New York Heart Association class I. Early postoperative arrhythmias developed in 3 patients (all were converted to sinus rhythm by antiarrhythmic drugs). There were no late deaths or reoperations.
Conclusions. The inclusion of a right-sided maze procedure with cardiac repair in patients having congenital heart anomalies that cause right atrial dilatation and associated atrial tachyarrhythmias is effective in eliminating or reducing the incidence of those arrhythmias.
| Introduction |
|---|
|
|
|---|
| Patients and Methods |
|---|
|
|
|---|
Documented atrial tachyarrhythmias included paroxysmal atrial fibrillation or flutter (n = 12) and chronic atrial fibrillation or flutter (n = 6). Fourteen patients were receiving antiarrhythmic drugs preoperatively, including digoxin, ß-receptor antagonists, calcium-channel antagonists, quinidine, propafenone, procainamide, and amiodarone, and 7 had required multiple electrocardioversions. Preoperative electrocardiography showed sinus rhythm in 12, atrial flutter in 4, and atrial fibrillation in 2 patients. The duration of documented atrial fibrillation or flutter ranged from 6 months to 54 years (mean, 14.2 years).
Follow-up information was obtained from correspondence with the patients and referring physicians and from telephone interviews conducted with all of the patients.
Surgical Technique
Cardiopulmonary bypass is instituted with standard cannulation of the ascending aorta for arterial inflow and direct cannulation of the superior and inferior venae cavae for venous drainage. The perfusate temperature is lowered to 25° to 30°C depending on the anticipated length of the procedure. A left ventricular vent is inserted through the right superior pulmonary vein and an aortic tack vent is placed.
Atrial septal defects are closed by direct suture or pericardial patch, and congenital tricuspid insufficiency is treated by valve repair, when feasible, or valve replacement. Our operative management of patients with Ebsteins anomaly is described in detail in previous reports from our institution [1] and consists of (1) electrophysiologic mapping for localization of accessory conduction pathways in those patients having ventricular preexcitation, (2) excision of any attenuated atrial septum and pericardial patch closure of the septal defect for patients having an atrial septal defect or patent foramen ovale, (3) selective plication of the atrialized right ventricle, (4) reconstruction of the tricuspid valve, when feasible, or valve replacement, (5) correction of associated anomalies such as relief of pulmonary stenosis and division of accessory conduction pathways, and (6) excision of redundant right atrial wall (right reduction atrioplasty).
Our modification of the Cox maze III procedure [5] is illustrated in Fig 1Fig 2Fig 3Fig 4Fig 5Fig 6. The right atrial appendage is excised and the first maze incision is made from the base of the resected appendage inferolaterally to within 3 to 4 cm of the inferior vena cava (Fig 1Fig 2). The second maze incision is made anteriorly full thickness through the atrial myocardium to the anterior aspect of the tricuspid annulus. The area at the annulus is cryoablated or, more recently, lightly electrocoagulated to ensure all remaining muscle fibers are ablated, and the incision is closed (Fig 3). The third incision is made from the superior vena cava to the inferior vena cava parallel to the plane of the atrial septum (Fig 3). The inferior end of this incision is repaired for approximately 2 cm. A fourth incision is made perpendicularly from the caudal portion of incision number 3 and carried to the posterolateral aspect of the tricuspid valve annulus (Fig 4). The area at the annulus is lightly electrocoagulated and the incision is partially repaired. If not required earlier to facilitate exposure, the aorta is then cross-clamped and the heart is arrested with cold blood cardioplegia and topical hypothermia. A fifth incision is made from the midportion of incision number 3 across the atrial septum and fossa ovalis, down to the tendon of Todaro near the coronary sinus; this incision is extended into the left atrium laterally for 1 to 2 cm and then closed (Fig 5).
|
|
|
|
|
|
| Results |
|---|
|
|
|---|
Most patients were paced atrially during weaning from cardiopulmonary bypass. There were no early deaths. No patient required intraaortic balloon pumping for hemodynamic support, and no patient had development of complete heart block or required early reoperation. Early postoperative complications included ventricular arrhythmia in 3 patients (multiple premature ventricular beats [n = 2]) and one run of nonsustained ventricular tachycardia) and prolonged (5 days) mechanical ventilation in 1 patient. An electrocardiogram at the time of hospital discharge showed sinus rhythm in 16 patients and junctional rhythm in 2 patients. The postoperative hospital stay ranged from 5 to 18 days (median, 7 days).
No late deaths have occurred in follow-up times ranging from 5.3 to 24 months (mean, 13 months). All patients are in functional class I and no patients have required late reoperation. One patient required placement of a dual-chamber rate-responsive pacemaker for chronotropic insufficiency with exercise. Late atrial arrhythmias developed in 3 patients at 3.0, 3.5, and 8.0 months postoperatively, respectively (mean 4.6 months). The rhythm was paroxysmal atrial flutter in 2 patients and paroxysmal atrial fibrillation in 1 patient. All three arrhythmias were converted to sinus rhythm by antiarrhythmic drugs with or without electrocardioversion. At last contact, 10 patients were receiving medications, including digoxin (n = 5), amiodarone (n = 2), ß-receptor antagonist (n = 2), and propafenone (n = 1). Late follow-up electrocardiograms ranging from 2.5 to 16 months (mean 9.3 months) showed 16 patients were in sinus rhythm (1 with intermittent pacemaker function) and 2 patients were in junctional rhythm.
| Comment |
|---|
|
|
|---|
The frequency of atrial arrhythmias in patients with Ebsteins anomaly varies among reported series, in part because of the ages of the patients in the series. The incidence of arrhythmias increases with age [7][9]. The mean duration of paroxysmal or chronic atrial fibrillation or flutter in the present series was 14.2 years. The mean age for patients in the present review (34.9 years) is considerably older than the mean age for our entire series of patients undergoing operation for Ebsteins anomaly (19.1 years) [1]. In a report from our institution, Oh and associates [2] reviewed 52 consecutive patients who underwent operation for Ebsteins anomaly. In this group, 18 patients (34.6%) had documented paroxysmal supraventricular tachycardia and 10 patients (19%) had paroxysmal atrial fibrillation or flutter preoperatively. Of the 10 patients with paroxysmal atrial fibrillation or flutter, one-third continued to have symptomatic atrial tachycardia when followed up for an average of 36 months after operation. A subsequent review at our institution [3, unpublished data] compared the incidence of preoperative and postoperative arrhythmias in 188 patients who underwent operation for Ebsteins anomaly. When patients with accessory conduction pathways were excluded, supraventricular tachycardia was present in 40% of the patients preoperatively and in 28% postoperatively during an average follow-up of 6 years. In a subgroup of 81 patients followed up for more than 6 years, there was no significant difference in the incidence of preoperative and postoperative atrial arrhythmias (42% versus 37%, respectively). These results included both persistence of preoperative atrial fibrillation or flutter and the development of new atrial fibrillation or flutter during the follow-up period.
Atrial tachyarrhythmias are poorly tolerated by patients with unrepaired congenital heart disease, and they may be a source of considerable morbidity and even mortality after successful cardiac repair [2][7]. The mechanism of death is presumably atrial fibrillation or flutter with rapid ventricular conduction or degeneration into ventricular fibrillation [7]. Treatment may require one or more antiarrhythmic drugs, most of which have a negative inotropic effect that may further depress myocardial function in patients with congenital heart disease. A pacemaker may also be required in combination with antiarrhythmic drugs for complete control of atrial tachyarrhythmias. For these reasons, although the incidence of postoperative atrial tachyarrhythmias is decreased by the standard repairs for the Ebstein and other congenital cardiac anomalies, we planned to institute a policy of performing a concomitant antiarrhythmia procedure in patients undergoing repair of congenital heart disease in whom atrial fibrillation or flutter was present on the basis of right atrial dilatation.
The Cox maze III operation is currently the surgical procedure of choice for management of medically refractory atrial fibrillation [5][10]. In addition to being used in patients with atrial fibrillation or flutter and no underlying structural disease, the maze procedure has been added to the operation for patients requiring mitral valve repair, closure of atrial septal defect, septal myectomy for hypertrophic obstructive cardiomyopathy, and coronary artery bypass grafting [11][12][13]. There have been two recent reports in which atrial incisions in the maze procedure have been applied to the left atrium only, with some beneficial reduction in late atrial fibrillation [14][15].
We modified the standard Cox maze III procedure by limiting the incisions to the right atrium and atrial septum. If effective, the right-sided maze would have several advantages over the standard maze operation including shorter operating time, minimizing the dissection necessary when dense adhesions are present, limiting the number of atrial suture lines, eliminating suture lines behind the heart where control of bleeding can be difficult, avoiding a possible postoperative noncontractile left atrium, and possibly decreasing the risk of systemic embolization. In addition, the decreased number of suture lines appears to decrease the tendency for postoperative fluid retention caused by a decrease in atrial natriuretic peptide. In this small series, the operation did not add to the operative or late mortality (both were zero), and there was a gratifying decrease in the incidence of atrial fibrillation or flutter from 100% to 17% (83% decrease). This decrease in preoperative supraventricular tachyarrhythmias, excluding those as a result of accessory conduction pathways, is greater than the reduction from 40% to 28% (30% decrease) that has been noted with the standard repair for Ebsteins anomaly [3] and other congenital lesions with right atrial enlargement in our experience.
For the standard maze procedure, early (<3 months) arrhythmias are common, ranging from 40% to 50% [10]. With the passage of time and further resolution of postoperative changes, this incidence decreases. Because all three of the arrhythmia occurrences in our review were early (mean of 4.6 months), this incidence may decrease in the months ahead. It remains to be seen how much improvement the patients in this review will experience and what the incidence of late arrhythmias will be. In the meantime, this experience has been encouraging enough that we plan to continue with concomitant right-sided maze procedures in patients with atrial fibrillation or flutter associated with a large right atrium and structural heart disease.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Giamberti, M. Chessa, S. Foresti, R. Abella, G. Butera, C. de Vincentiis, M. Carminati, L. Menicanti, and A. Frigiola Combined atrial septal defect surgical closure and irrigated radiofrequency ablation in adult patients. Ann. Thorac. Surg., October 1, 2006; 82(4): 1327 - 1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Stulak, J. A. Dearani, R. C. Daly, K. J. Zehr, T. M. Sundt III, and H. V. Schaff Left Ventricular Dysfunction in Atrial Fibrillation: Restoration of Sinus Rhythm by the Cox-Maze Procedure Significantly Improves Systolic Function and Functional Status Ann. Thorac. Surg., August 1, 2006; 82(2): 494 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Stulak, J. A. Dearani, F. J. Puga, K. J. Zehr, H. V. Schaff, and G. K. Danielson Right-sided maze procedure for atrial tachyarrhythmias in congenital heart disease. Ann. Thorac. Surg., May 1, 2006; 81(5): 1780 - 1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Karamlou, I. Silber, R. Lao, B. W. McCrindle, L. Harris, E. Downar, G. D. Webb, J. M. Colman, G. S. Van Arsdell, and W. G. Williams Outcomes after late reoperation in patients with repaired tetralogy of fallot: the impact of arrhythmia and arrhythmia surgery. Ann. Thorac. Surg., May 1, 2006; 81(5): 1786 - 1793. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. S. Boston, J. A. Dearani, P. W. O'Leary, D. J. Driscoll, and G. K. Danielson Tricuspid Valve Repair for Ebstein's Anomaly in Young Children: A 30-Year Experience Ann. Thorac. Surg., February 1, 2006; 81(2): 690 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-H. Kim, H. G. Lim, J. R. Lee, J. R. Rho, E. J. Bae, C. I. Noh, Y. S. Yoon, and Y. J. Kim Fontan conversion with arrhythmia surgery Eur. J. Cardiothorac. Surg., February 1, 2005; 27(2): 250 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Khositseth, G. K. Danielson, J. A. Dearani, T. M. Munger, and C. J. Porter Supraventricular tachyarrhythmias in Ebstein anomaly: Management and outcome J. Thorac. Cardiovasc. Surg., December 1, 2004; 128(6): 826 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lim, J. Y. Lee, W.-H. Kim, S.-C. Kim, J.-Y. Song, S.-J. Kim, J.-H. Choh, and C. Whan Kim Early replacement of pulmonary valve after repair of tetralogy: is it really beneficial? Eur. J. Cardiothorac. Surg., May 1, 2004; 25(5): 728 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Bermudez, J. A. Dearani, F. J. Puga, H. V. Schaff, C. A. Warnes, P. W. O'Leary, C. D. Schleck, and G. K. Danielson Late results of the peel operation for replacement of failing extracardiac conduits Ann. Thorac. Surg., March 1, 2004; 77(3): 881 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Deal, C. Mavroudis, and C. L. Backer Beyond Fontan conversion: surgical therapy of arrhythmias including patients with associated complex congenital heart disease Ann. Thorac. Surg., August 1, 2003; 76(2): 542 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Setty, K. Finucane, J. R. Skinner, and A. R. Kerr Extracardiac conduit with a limited maze procedure for the failing Fontan with atrial tachycardias Ann. Thorac. Surg., December 1, 2002; 74(6): 1992 - 1997. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. Louagie, D. Blommaert, and L. De Roy Radiofrequency ablation of atrial flutter combined with closure of atrial septal defect Interactive CardioVascular and Thoracic Surgery, September 1, 2002; 1(1): 38 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Kopf, D. M. Mello, K. M. Kenney, J. Moltedo, N. R. Rollinson, and C. S. Snyder Intraoperative radiofrequency ablation of the atrium: effectiveness for treatment of supraventricular tachycardia in congenital heart surgery Ann. Thorac. Surg., September 1, 2002; 74(3): 797 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Kress, D. Krum, V. Chekanov, J. Hare, N. Michaud, M. Akhtar, and J. Sra Validation of a left atrial lesion pattern for intraoperative ablation of atrial fibrillation Ann. Thorac. Surg., April 1, 2002; 73(4): 1160 - 1168. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mavroudis, C. L. Backer, B. J. Deal, C. Johnsrude, and J. Strasburger Total cavopulmonary conversion and maze procedure for patients with failure of the Fontan operation J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 863 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-B. Kim, J.-H. Huh, C. H. Kang, H. Ahn, and D.-W. Sohn Modifications of the Cox-Maze III procedure Ann. Thorac. Surg., March 1, 2001; 71(3): 816 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Discigil, J. A. Dearani, F. J. Puga, H. V. Schaff, D. J. Hagler, C. A. Warnes, and G. K. Danielson Late pulmonary valve replacement after repair of tetralogy of Fallot J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 0344 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Dearani and G. K. Danielson Congenital Heart Surgery Nomenclature and Database Project: Ebstein's anomaly and tricuspid valve disease Ann. Thorac. Surg., April 1, 2000; 69(4): S106 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Overgaard, D. A. Harrison, S. C. Siu, W. G. Williams, G. D. Webb, and L. Harris Outcome of previous tricuspid valve operation and arrhythmias in adult patients with congenital heart disease Ann. Thorac. Surg., December 1, 1999; 68(6): 2158 - 2163. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Nomura, K. Finucane, W. Smith, and A. R. Kerr The failing Fontan with atrial flutter: a successful surgical option Ann. Thorac. Surg., November 1, 1999; 68(5): 1845 - 1848. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Berger, M. Vogel, A. Kramer, V. Alexi-Meskishvili, Y. Weng, P. E. Lange, and R. Hetzer Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery Ann. Thorac. Surg., July 1, 1999; 68(1): 75 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Kiziltan, D. A. Theodoro, C. A. Warnes, P. W. O'Leary, B. J. Anderson, and G. K. Danielson Late results of bioprosthetic tricuspid valve replacement in Ebstein's anomaly Ann. Thorac. Surg., November 1, 1998; 66(5): 1539 - 1545. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |